Elix, Inc. (CEO: Shinya Yuki / HQ: Tokyo, hereinafter "Elix"), an AI drug discovery company with the mission of "Rethinking ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

Japanese biotech Prism BioLab has entered a strategic partnership with AI drug discovery company Elix to accelerate the ...

PRISM BioLab , today announced that it has entered into a drug discovery collaboration with Elix, effective April 1, 2025.

ELIX Polymers works in partnership with Repsol and AnQore to produce feedstock materials to help produce 100 percent recycled-content ABS plastic. ELIX Polymers says it signed agreements with both ...

PRISM BioLab & Elix join forces to speed up AI-driven drug discovery for protein-protein interaction targets: Tokyo, Japan Tuesday, April 15, 2025, 16:00 Hrs [IST] PRISM BioLab, C ...

Through this partnership, PRISM BioLab's proprietary small molecule peptide-mimetic PepMetics® technology will be integrated with Elix's AI drug discovery platform "Elix Discovery™." ...

Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform TOKYO, April 14, 2025 /PRNewswire/ -- ...